Subsequent Events	12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	15. SUBSEQUENT EVENTS On January 14, 2022, the Company entered into an At Market Offering Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”) pursuant to which the Company may sell, from time to time, shares of the Company’s common stock, par value $0.01 per share, having an aggregate offering price of up to $15,000,000, through the Agent. As of the date of this filing, under the Sales Agreement, the Company has sold and issued an aggregate of 65,843 shares of our common stock and raised aggregate gross proceeds of approximately $403,364, less sales commissions of approximately $8,069. On March 1, 2022, the Company declared a cash dividend of $0.065 per common share payable on March 31, 2022 to stockholders of record as of March 15, 2022. On March 28, 2022, the Company approved restricted share awards under the Plan to certain of its officers and employees in the aggregate amount of 26,025 shares, of which 15,025 shares are performance-based grants and the remainder of the shares are time-based grants. Between 0% and 200% of these shares will be earned based on achievement of the AFFO and SSRG goals in 2022, and the shares which are earned will remain subject to quarterly vesting during the remaining four-year time vesting period. Dividends paid by the Company prior to the determination of how many shares are earned will be retained by the Company and released only with respect to earned shares. If a Change in Control (as defined in the Plan) occurs during 2022, the number of shares earned will equal the greater of the number of shares granted and the number of shares which would have been earned based on the AFFO and SSRG through the date of the Change in Control. If following a Change in Control, a grantee is terminated by the Company without Cause or by the grantee with Good Reason (as each is defined in the Plan), all unvested restricted shares will fully vest.

Subsequent Events

12 Months Ended

Dec. 31, 2021

15. SUBSEQUENT EVENTS

On January 14, 2022, the Company entered into an At Market Offering Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”) pursuant to which the Company may sell, from time to time, shares of the Company’s common stock, par value $0.01 per share, having an aggregate offering price of up to $15,000,000, through the Agent. As of the date of this filing, under the Sales Agreement, the Company has sold and issued an aggregate of 65,843 shares of our common stock and raised aggregate gross proceeds of approximately $403,364, less sales commissions of approximately $8,069.

On March 1, 2022, the Company declared a cash dividend of $0.065 per common share payable on March 31, 2022 to stockholders of record as of March 15, 2022.

On March 28, 2022, the Company approved restricted share awards under the Plan to certain of its officers and employees in the aggregate amount of 26,025 shares, of which 15,025 shares are performance-based grants and the remainder of the shares are time-based grants. Between 0% and 200% of these shares will be earned based on achievement of the AFFO and SSRG goals in 2022, and the shares which are earned will remain subject to quarterly vesting during the remaining four-year time vesting period. Dividends paid by the Company prior to the determination of how many shares are earned will be retained by the Company and released only with respect to earned shares. If a Change in Control (as defined in the Plan) occurs during 2022, the number of shares earned will equal the greater of the number of shares granted and the number of shares which would have been earned based on the AFFO and SSRG through the date of the Change in Control. If following a Change in Control, a grantee is terminated by the Company without Cause or by the grantee with Good Reason (as each is defined in the Plan), all unvested restricted shares will fully vest.